We have analyzed a pair of human myeloma immunoglobulins (biclonal proteins) of the IgG and IgA classes from a single patient, GR 
marrow as some differentiate into lymphocytes (3, 4) . As the animal matures, lymphocytes migrate to the peripheral lymphoid organs (spleen and lymph nodes) where they undergo their final differentiation steps upon contact with antigen. This process produces plasma cells which are specialized to produce thousands of antibody molecules per second and memory cells which are responsible for the enhanced secondary immune response.
In molecular terms three generalizations are commonly accepted about the differentiation of antibody-producing cells (see ref . 5 Rare cancerous or neoplastic transformations can apparently occur at any stage in the differentiation of antibodyproducing cells (2). Chronic lymphocytic leukemia and Burkitt's lymphoma involve B lymphocytes at an early stage of differentiation. The macroglobulinemia of Waldenstr6m represents an accumulation of cells in transition from B lymphocytes to mature antibody-producing cells. Multiple myeloma results in the neoplastic proliferation of a single type of mature plasma cell and, indeed, is the source of homogeneous myeloma immunoglobulins, the structural analysis of which has led to many of the generalizations outlined above.
A special form of multiple myeloma is beginning to provide new insights into the differentiation process of B cells. Occasionally, individuals with multiple myeloma synthesize large quantities of two distinct myeloma immunoglobulins. Serological and chemical studies on the best-studied example of biclonal myeloma proteins from the human patient, Til, suggest that the light chains and VH regions in the IgM and IgG myeloma proteins are very similar, if not identical (6) (7) (8) (9) . These molecular observations, together with those from a variety of cellular studies, suggest that a B lymphocyte initially has IgM receptors and that, in the course of differentiation, subclones arise which synthesize IgG molecules with precisely the same specificity. That is, the light chain expressed in this clone of antibody-producing cells remains the same throughout the differentiation process while the VH gene is expressed first in association with a C,, gene (IgM) and then in association with a C, gene (IgG). Thus, a fundamental aspect of differentiation in B cells is the association of one VH gene with two or more CH genes.
Preliminary reports have indicated that IgA and IgG immunoglobulins from patients with biclonal myeloma proteins also have similar light chains and VH regions (10) (11) (12) . Asp-lle-Gln-Met-Thr-Gln-Ser-Pro-Ser-Ser-Leu-Ser-Ala-Ser-Val-Gly-Asp-Arg- (Fig. 1) . The unique relationship of these light chains is emphasized by the fact they share two residues (i.e., positions 27 and 39) never before seen in more than 80 human VK sequences (15, 16) and have identical first hypervariable regions. Furthermore, amino-acid analyses, comparisons of chromatograms in three different systems, electrophoretic mobilities in five different systems, and isoelectric focusing are all consistent with the identity of these two light chains (13) . Accordingly, this evidence strongly supports the identity of the light chains from the GR IgA and IgG immunoglobulins.
The VH regions from the GR biclonal proteins are identical over their NHg-terminal 45 residues (Fig. 2) . The identity of these VH regions throughout the extremely diverse first hypervariable region, as well as the observation that three residues are shared by these VH regions that have not previously been seen in more than 25 human VH regions (i.e., residues 33, 38, and 43), suggest that these VH regions are uniquely related and very similar if not identical to one another (15, 17, 20) . Supporting this supposition is the fact that both the IgA and IgG proteins from GR share their individual antigenic determinants (12) .
Caution, however, must be used in attempts to extrapolate V region identity from partial amino-acid sequence data. Examples are known in which heavy chains identical through the first hypervariable region have residue differences at later positions in the variable region (see Fig. 7 in ref. 1). Indeed, the amino-acid sequence data from biclonal immunoglobulins accumulated to date on the presumptive identity of VH regions are surprisingly meager (11, 18) . Even with the immunoglobulins of the most thoroughly studied biclonal patient, Til, the sequences of the first and last hypervariable regions of the y and IA heavy chains were not completely determined (compare the VH sequences in refs. 7 and 17), and no sequence data are available for the second hypervariable region. Thus, apart from this study, the sequences of no active-site associated hypervariable regions have been completely determined in the VH regions of a biclonal pair.
With the reservations above noted, we conclude that simi- 10 20 Prototype VHIII Glu-Val-Gln-Leu-Val-Glu-Ser-Gly-Gly-Gly-Leu-Val-Gln-Pro-Gly-Gly-Ser-Leu-Arg-Leu-Ser-Cys-Ala- (Fig. 3 , model a). The differentiation process would then consist of the successive activation of complete VH-CH genes by conventional mechanisms of gene regulation (36) . We have termed this the simultaneous insertional model. Second, a single VH gene could, as others have postulated (9) , "switch" from one CH gene to a second (or even a third) during the differentiation process. Accordingly, each cell could only transcribe a single VH-CH gene at a particular point in time (Fig. 3, model b (37) . Accordingly, the specificity of the IgD and IgM molecules appears to be identical. Second, the idiotype of IgM and IgD molecules found on the majority of peripheral B lymphocytes in a patient with chronic lymphocytic leukemia and macroglobulinemia is the same (27 VIs ments in the future may be able to differentiate between one or two VH genes (successive insertional model) and ten or more VH genes (simultaneous insertional model).
A variety of specific V-C joining mechanisms have been proposed (see ref. 38) . The "copy-splice" model suggests that a given V gene may be copied and spliced onto one or more C genes (39) . The "episomal" model suggests that a V gene may be converted into an episome and then reintegrated back into the genome adjacent to one or more CH genes (40) . The "looping out" model suggests that a V gene may be joined to a C gene by deleting as a circle all the intervening DNA. When this same V gene is joined to a new C gene, once again the intervening genetic material is lost as a circle (2, 41). Thus, a "looping out" process would successively join a V gene with different C genes. Finally, the "lateral gene duplication" model suggests a branching network of V and C genes which simultaneously places every VH gene adjacent to every CH gene (42) . Control switches would then determine which VH-CH combination was transcribed. The first two mechanisms are compatible with either of the models described in the preceding paragraph, whereas the latter two are only possible with the successive insertional model. Because of the observations discussed in the preceding paragraph, one of the first two mechanisms appears more likely.
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